EUVIMEDEUVIMED entdecken
Open Access

Ursoricin, a bacteriocin of Streptococcus ursoris , has potent activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci

Chutian Wang iD, Mi Nguyen-Tra Le iD, Miki Kawada-Matsuo iD, Junzo Hisatsune iD, Yo Sugawara iD, Chika Arai, Jun Nakanishi, Katsuhiro Takeda, Hideki Shiba, Motoyuki Sugai iD, Hitoshi Komatsuzawa iD

Applied and Environmental Microbiology · 2024

DOI: 10.1128/aem.00162-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied and Environmental Microbiology, 2024. Verfasst von Chutian Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Bacteriocins, Anti-Bacterial Agents, Vancomycin-Resistant Enterococci, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of drug-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), has increased the need to discover novel antimicrobial agents that are effective against these species. Here, we describe the identification and purification of the mutacin BHT-B-like gene locus and bacteriocin peptide from Streptococcus ursoris , which is closely related to Streptococcus ratti ; hence, we named this bacteriocin ursoricin. Ursoricin is a cationic, chromosome-encoded peptide that has potent antimicrobial effects against Gram-positive pathogens, including MRSA and VRE, with minimum inhibitory concentrations in the micromolar range. Ursoricin also inhibits the biofilm formation of high biofilm-forming S. aureus . Antibacterial activity was retained after treatment at 100°C for 60 min at a pH range of 3–9 and was partially reduced by treatment with proteinase K for 2 h (63% residual activity). The potent anti-MRSA, anti-VRE, and antibiofilm effects of ursoricin suggest that it is a possible candidate for the treatment of MRSA, VRE, and biofilm-associated infections. IMPORTANCE The emergence of multidrug-resistant bacteria worldwide has posed a significant public health threat and economic burdens that make the identification and development of novel antimicrobial agents urgent. Bacteriocins are promising new agents that exhibit antibacterial activity against a wide range of human pathogens. In this study, we report that the bacteriocin produced by Streptococcus ursoris showed good antibacterial activity against a wide range of Staphylococcus aureus and enterococcus strains, particularly methicillin-resistant Staphylococcus aureus , vancomycin-resistant enterococci, and high biofilm-forming S. aureus . Interestingly, this bacteriocin had a stronger effect on S. aureus than on Staphylococcus epidermidis , which is a major commensal bacterium in human skin; this result is important when considering the disturbance of bacterial flora, especially on the skin, mediated by the application of antibacterial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriocinsAnti-Bacterial AgentsVancomycin-Resistant EnterococciMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsBiofilmsStreptococcus

Stichwörter der Autor:innen

Streptococcus ursorisanti-MRSAanti-VREantimicrobial peptidebacteriocinursoricin

Substanzen

BacteriocinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Bacteriology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Project Research Centre for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan.
  • Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

ORCID-Profile: Chutian Wang, Mi Nguyen-Tra Le, Miki Kawada-Matsuo, Junzo Hisatsune, Yo Sugawara, Motoyuki Sugai, Hitoshi Komatsuzawa

Förderung

  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Wang, C., Le, M. N. T., Kawada-Matsuo, M., Hisatsune, J., Sugawara, Y., Arai, C., Nakanishi, J., Takeda, K., Shiba, H., Sugai, M., & Komatsuzawa, H. (2024). Ursoricin, a bacteriocin of Streptococcus ursoris , has potent activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.00162-24

Vancouver

Wang C, Le MNT, Kawada-Matsuo M, Hisatsune J, Sugawara Y, Arai C, et al. Ursoricin, a bacteriocin of Streptococcus ursoris , has potent activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Applied and Environmental Microbiology. 2024. doi:10.1128/aem.00162-24

BibTeX
@article{Wang2024,
  author = {Wang, Chutian and Le, Mi Nguyen-Tra and Kawada-Matsuo, Miki and Hisatsune, Junzo and Sugawara, Yo and Arai, Chika and Nakanishi, Jun and Takeda, Katsuhiro and Shiba, Hideki and Sugai, Motoyuki and Komatsuzawa, Hitoshi},
  title = {Ursoricin, a bacteriocin of Streptococcus ursoris , has potent activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci},
  journal = {Applied and Environmental Microbiology},
  year = {2024},
  doi = {10.1128/aem.00162-24}
}
Kostenlos starten →